1767482378a:6:{i:0;O:8:"stdClass":2:{s:4:"icId";s:5:"E75.0";s:15:"icJenisPenyakit";s:18:"GM2 gangliosidosis";}i:1;O:8:"stdClass":2:{s:4:"icId";s:5:"E75.1";s:15:"icJenisPenyakit";s:20:"Other gangliosidosis";}i:2;O:8:"stdClass":2:{s:4:"icId";s:5:"G51.1";s:15:"icJenisPenyakit";s:23:"Geniculate ganglionitis";}i:3;O:8:"stdClass":2:{s:4:"icId";s:5:"M67.4";s:15:"icJenisPenyakit";s:8:"Ganglion";}i:4;O:8:"stdClass":2:{s:4:"icId";s:5:"T44.2";s:15:"icJenisPenyakit";s:64:"Poisoning by ganglionic blocking drugs, not elsewhere classified";}i:5;O:8:"stdClass":2:{s:4:"icId";s:5:"Y51.2";s:15:"icJenisPenyakit";s:93:"Adverse effects in the therapeutic use of ganglionic blocking drugs, not elsewhere classified";}}